日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Construction and Validation of a Clinical Pregnancy Outcome Prediction Model for Infertility Treatment Using IVF/ICSI: A Retrospective Study Based on 11,449 Cases

基于11449例病例的回顾性研究:构建和验证体外受精/卵胞浆内单精子注射不孕症治疗临床妊娠结局预测模型

Guo, Yan; Luo, Yonghan; Li, Yunxiu; Feng, Yun; Zhang, Jie; Yan, Jiacong; Ai, Ying; Tan, Jiahong; Zhao, Han; Zou, Xiu; Li, Man; Wu, Ze; Xiang, Lifeng; Xia, Xueshan

Correction to: CEBPB regulates ERK1/2 activity through SOS1 and contributes to ovarian cancer progression

更正:CEBPB 通过 SOS1 调节 ERK1/2 活性并促进卵巢癌进展

Tan, Jiahong; Wang, Daoqi; Tu, Aiqing; Xu, Qin; Zhuan, Li; Wu, Xiaodie; Zhao, Lin; Dong, Wei; Zhang, Jie; Feng, Yun

CEBPB regulates ERK1/2 activity through SOS1 and contributes to ovarian cancer progression.

CEBPB 通过 SOS1 调节 ERK1/2 活性,并促进卵巢癌的进展

Tan Jiahong, Wang Daoqi, Tu Aiqing, Xu Qin, Zhuan Li, Wu Xiaodie, Zhao Lin, Dong Wei, Zhang Jie, Feng Yun

CEBPB activates NRF2 to regulate the MAPK pathway through DUSP1 to promote proliferation and antioxidant capacity in ovarian cancer cells.

CEBPB 激活 NRF2,通过 DUSP1 调节 MAPK 通路,从而促进卵巢癌细胞的增殖和抗氧化能力

Tan Jiahong, Wang Daoqi, Dong Wei, Zhang Jinman, Li Yuanyue, Zhao Lin, Wu Xiaodie, Ren Li, Zhang Jie, Feng Yun

CEBPB promotes transformation of endometrial complex atypical hyperplasia to endometrial cancer.

CEBPB促进子宫内膜复杂非典型增生向子宫内膜癌的转化

Tan Jiahong, Zhao Lin, Wang Daoqi, Wu Xiaodie, Bi Yongxiang, Wang Hanying, Ma Na, Yang Dehong, Dong Wei, Zhang Jie

Correction: Protein expression profiling identifies a prognostic model for ovarian cancer

更正:蛋白质表达谱分析确定了卵巢癌的预后模型

Xiong, Luyang; Tan, Jiahong; Feng, Yuchen; Wang, Daoqi; Liu, Xudong; Feng, Yun; Li, Shusheng

Clinical characteristics and influencing factors of adverse outcomes following clinical pregnancy after laparoscopic tubal anastomosis

腹腔镜输卵管吻合术后临床妊娠不良结局的临床特征及影响因素

Guo, Yan; Liu, Xiaochuan; Zhang, Yuanyuan; Ke, Yunmei; Liu, Jia; Tan, Jiahong; Zhu, Yun; Ma, Na; Luo, Yonghan; Zhang, Jie

Corrigendum to "SEMA4D acts as a novel oligogenic pathogenic gene of idiopathic hypogonadotropic hypogonadism through the PlexinB1/MET/RND1/RHOA/RAF1/MAPK signaling axis" [Genes & Diseases 10 (2023) 65-68]

对“SEMA4D 通过 PlexinB1/MET/RND1/RHOA/RAF1/MAPK 信号轴作为特发性低促性腺激素性性腺功能减退症的新型寡基因致病基因”的更正 [Genes & Diseases 10 (2023) 65-68]

Wang, Daoqi; Niu, Yonghua; Tan, Jiahong; Wang, Jiaxin; Ling, Le; Chen, Yinwei; Gong, Jianan; Xu, Hao; Ling, Qing; Liu, Jianhe; Liu, Jihong

Impact of body mass index on size and composition of urinary stones: a systematic review and meta-analysis

体重指数对泌尿系结石大小和成分的影响:系统评价和荟萃分析

Wang, Daoqi; Tan, Jiahong; Geng, Erkang; Wan, Chuanping; Xu, Jinming; Yang, Bin; Zhou, Yuan; Zhou, Guiming; Ye, Zhenni; Li, Jiongming; Liu, Jianhe

SEMA4D acts as a novel oligogenic pathogenic gene of idiopathic hypogonadotropic hypogonadism through the PlexinB1/MET/RND1/RHOA/RAF1/MAPK signaling axis

SEMA4D 通过 PlexinB1/MET/RND1/RHOA/RAF1/MAPK 信号通路,作为一种新型的寡基因致病基因,在特发性低促性腺激素性性腺功能减退症中发挥作用。

Wang, Daoqi; Niu, Yonghua; Tan, Jiahong; Wang, Jiaxin; Ling, Le; Chen, Yinwei; Gong, Jianan; Xu, Hao; Ling, Qing; Liu, Jianhe; Liu, Jihong